Activated charcoal for pediatric poisonings: The universal antidote?

Current Opinion in Pediatrics

Volumn 19, Issue 2, 2007, Pages 216-222

  Lapus, Robert Michael ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

Antidote; Charcoal; Decontamination; Ingestion; Overdose; Poison

Indexed keywords

CHARCOAL;

ADSORPTION; ASPIRATION; CONCENTRATION (PARAMETERS); CONSTIPATION; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG ELIMINATION; EMERGENCY CARE; ESOPHAGUS PERFORATION; HOSPITALIZATION; HUMAN; INTOXICATION; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SIDE EFFECT; SMALL INTESTINE OBSTRUCTION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VOMITING;

ANTIDOTES; CHARCOAL; CHILD; HUMANS; POISONING;

EID: 34247588535     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32801da2a9     Document Type: Review

References (49)

1. Watson WA, Litovitz TL, Rodgers GC. 2004 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 2005; 23:589-666. Annual comprehensive report which provides statistics on exposures reported to poison centers in 2004.
2. Historical production and use of carbon materials. http://www.caer.uky. edu/carbon/history/carbonhistory.shtml. [Accessed 26 October 2006]
3. Marketos SG, Androutsos G. Charcoal: from antiquity to charcoal artificial kidney. J Nephrol 2004; 17:453-456.
4. Derlet RW, Albertson TE. Activated charcoal: past present and future. West J Med 1986; 145:493-496.
5. Erickson TB. Toxicology: ingestions and smoke inhalations: APLS. In: Gausche-Hill M, Fuchs S, Yamamoto L, editors. The pediatric emergency resource. 4th ed. Massachusetts: Jones and Bartlett; 2004. p. 239.
6. Chyka PA, Seger D, Krenzelok EP, Vale JA. American Academy of Clinical Toxicology and European Association of Poison Centres and Clinical Toxicologists. Position paper: Single-dose activated charcoal. Clin Toxicol 2005; 43:61-87. Evidence-based position paper regarding the use of single dose activated charcoal: indications, contraindications, dosages, adverse effects. Summarizes clinical studies and provides abstracts of the role of charcoal for ingestion of several drugs.
7. Gaudreault P. Activated charcoal revisited. Clin Ped Emerg Med 2005; 6:76-80. Concise review article that discusses indications, dosages, adverse effects and benefits of SDAC and MDAC.
8. Olkkola KT, Neuvonen PJ. Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol 1984; 18:663-669.
9. Neuvonen PJ, Olkkola KT, Alanen T. Effect of ethanol and pH on the adsorption of drugs to activated charcoal: studies in vitro and in man. Acta Pharm Toxicol 1984; 54:1-7.
10. Andersen A. Experimental studies on the pharmacology of activated charcoal. II: The effect on pH on the adsorption by charcoal from aqueous solutions. Acta Pharmacol 1947; 3:199-218.
11. Andersen A. Experimental studies on the pharmacology of activated charcoal. III: Adsorption from gastric contents. Acta Pharmacol 1948; 4:275-284.
12. Spiller HA, Krenzelok EP, Grande GA, Safir EF. A prospective evaluation of the effect of activated charcoal before oral N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994; 23:519-523.
13. Montoya-Cabrera MA, Escalante-Galindo P, Nava-Juarez A, Terrobo-Larios VM. Evaluation of the efficacy of the N-acetylcysteine administration alone or in combination with activated charcoal in the treatment of acetaminophen overdose. Gac Med Mex 1999; 135:239-243.
14. Rose SR, Gorman RL, Oderda GM, Klein-Schwartz W. Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal. Ann Emerg Med 191; 20:106-108.
15. Sato RL, Wong JJ, Sumida SM, Marn RY. Efficacy of superactivated charcoal administered late (3 h) after acetaminophen overdose. Am J Emerg Med 2003; 21:189-191.
16. Spiller HA, Winder ML, Klein-Schwartz W, Bangh SA. Efficacy of activated charcoal administered more than four hours after acetaminophen overdose. J Emerg Med 2006; 30:1-5. Multicenter, prospective observational study examining the impact late administration of charcoal has on hepatic transaminases in acetaminophen overdose.
17. Vale JA, Krenzelok EP, Barceloux GD. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. Clin Toxicol 1999; 37:731-751.
18. Tenenbein M. Multiple doses of activated charcoal: time for reappraisal II. Ann Emerg Med 2003; 42:597-598.
19. Merigian KS, Blaho KE. Single-dose oral activated charcoal in the treatment of the self-poisoned patient: a prospective, randomized, controlled trial. Am J Therapeut 2002; (9):301-308.
20. Cooper GM, Le Couteur DG, Richardson D, Buckley NA. A randomized clinical trial of activated charcoal for the routine management of oral drug overdose. Q J Med 2005; 98:655-660. Randomized, controlled trial comparing outcome in overdose patients who did and did not receive charcoal.
21. Kornberg AE, Dolgin J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann Emerg Med 1991; 20:648-651.
22. Osterhoudt KC, Alpern ER, Burden D, et al. Activated charcoal administration in the pediatric emergency department. Pediatr Emerg Care 2004; 20:493-498.
23. Alaspää AO, Kulsma MJ, Hoppu Kalle, Neuvonen PJ. Out-of-hospital administration of activated charcoal by emergency medical services. Ann Emerg Med 2005; 2: 207-212. Prospective study in a developed country examining the feasibility of prehospital administration of activated charcoal.
24. Holstege CP, Baer AB. Decontamination of the poisoned patients: In: Roberts JR, Hedges J, Chanmugam AS, editors. Clinical procedures in emergency medicine. 4th ed. Philadelphia: WB Saunders; 2004. pp. 824-837.
25. Fischer TF, Singer AJ. Comparison of the palatabilities of standard and superactivated charcoal in toxic ingestions: a randomized trial. Acad Emerg Med 1999; 6:895-899.
26. Harchelroad F, Cottington E, Krenzelok EP. Gastrointestinal transit times of a charcoal/sorbitol slurry in overdose patients. J Toxicol Clin Toxicol 1989; 27:91-99.
27. Pond SM, Lewis-Driver DJ, Williams GM. Gastric emptying in acute overdose: a prospective, randomized control trial. Med J Aust 1995; 163:345-349.
28. Rangan C, Nordt SP, Hamilton R. Treatment of acetaminophen ingestion with superactivated charcoal-cola mixture. Ann Emerg Med 2001; 37:55-58.
29. Minocha A, Krenzelok EP, Spyker DA. Dosage recommendations for activated charcoal-sorbitol treatment. J Toxicol Clin Toxicol 1985; 23:579-587.
30. Neuvonen PJ. Clinical pharmacokinetics of oral activated charcoal in acute intoxications. Clin Pharmacokinet 1982; 7:465-489.
31. Osterhoudt KC, Durbin D, Alpern ER, Henretig FM. Risk factors for emesis after therapeutic use of activated charcoal in acutely poisoned children. Pediatrics 2004; 113:806-810.
32. Eizember FL, Tomaszewski CA, Kerns IIWP. Acupressure for prevention of emesis in patients receiving activated charcoal. J Toxicol Clin Toxicol 2002; 40:775-780.
33. Heard K. The changing indications of gastrointestinal decontamination in poisoning. Clin Lab Med 2006; 26:1-12. Review article discussing the various methods of gastric decontamination with recent literature citations and summary recommendations.
34. Dorrington CL, Johnson DW, Brant R. The frequency of complication associated with the use of multiple-dose activated charcoal. Ann Emerg Med 2003; (42):370-377.
35. Liisanantti J, Paivi K, Matti M. Aspiration pneumonia following severe self-poisoning. Resuscitation 2003; 56:49-53.
36. Isbister GK, Downes F, Sibbritt D. Aspiration pneumonitis in an overdose population: frequency, predictors, and outcomes. Crit Care Med 2004; 32:88-93.
37. Arnold TC, Willis BH, Xiao F. Aspiration of activated charcoal elicits an increase in lung microvascular permeability. J Toxicol Clin Toxicol 1999; 37:1-8.
38. Graff GR, Stark J, Berkenbosch JW. Chronic lung disease after activated charcoal aspiration. Pediatrics 2002; 109:959-961.
39. Seger D. Single-dose activated charcoal: back up and reassess. J Toxicol Clin Toxicol 2004; 42:101-110.
40. Elliot CG, Colby TV, Kelly TM, Hicks HG. Bronchiolitis obliterans after aspiration of activated charcoal. Chest 198; 96:672-674.
41. Aaron CK, Primack WA, Manno MA, Fairfield S. Cardiac arrest from aspirated magnesium citrate/charcoal slurry. Clin Toxicol 1997; 35:505.
42. Moll J, Kerns IIW, Tomaszewski C. Incidence of aspiration pneumonia in intubated patients receiving activated charcoal. J Emerg Med 1999; 17:279-283.
43. Thibodeau LG, Verdile VP, Batfield JM. Incidence of aspiration after urgent intubation. Am J Emerg Med 1997; 15:562-565.
44. American Association of Poison Control Centers. Toxic Exposure Surveillance System report; 2004. Case 133.
45. Caravati EM, Knight HH, Linscott MS Jr. Esophageal laceration and charcoal mediastinum complicating gastric lavage. J Emerg Med 2001; 20:273-276.
46. Mariani PJ, Pook N. Gastrointestinal tract perforation with charcoal peritoneum complicating orogastric intubation and lavage. Ann Emerg Med 1993; 22:606-609.
47. Gomez HF, Brent JA, Munoz DC IV. Charcoal stercolith with intestinal perforation in a patient treated for amitriptyline ingestion. J Emerg Med 1994; 12:57-60.
48. Chan JC, Saranasuriya C, Waxman BP. Bezoar causing small bowel obstruction after repeated activated charcoal administration. Med J Aust 2005; 183:537.
49. McKinny P, Phillips S, Gomez HG, Brent J. Corneal abrasions secondary to activated charcoal. Vet Hum Toxicol 1992; 34:336.